chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Dizzy every now and then; Hard to walk; back pain; arm and leg pain; arm and leg pain; Fever between 99.1-100 F; Vomiting; Not been to work; This spontaneous case was reported by an other health care professional and describes the occurrence of DIZZINESS (Dizzy every now and then), GAIT DISTURBANCE (Hard to walk), BACK PAIN (back pain), the first episode of PAIN IN EXTREMITY (arm and leg pain) and the second episode of PAIN IN EXTREMITY (arm and leg pain) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, the patient experienced DIZZINESS (Dizzy every now and then), GAIT DISTURBANCE (Hard to walk), BACK PAIN (back pain), the first episode of PAIN IN EXTREMITY (arm and leg pain), the second episode of PAIN IN EXTREMITY (arm and leg pain), PYREXIA (Fever between 99.1-100 F), VOMITING (Vomiting) and FATIGUE (Not been to work). On 07-Feb-2021, PYREXIA (Fever between 99.1-100 F) outcome was unknown. On 08-Feb-2021, VOMITING (Vomiting) had resolved. At the time of the report, DIZZINESS (Dizzy every now and then), GAIT DISTURBANCE (Hard to walk), BACK PAIN (back pain), the last episode of PAIN IN EXTREMITY (arm and leg pain) and FATIGUE (Not been to work) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information not provided. Treatment information not provided
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: Nausea; Fever; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), PYREXIA (Fever) and VOMITING (Vomiting) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included No adverse event and No adverse event. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL N).    On 10-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced NAUSEA (Nausea), PYREXIA (Fever) and VOMITING (Vomiting). At the time of the report, NAUSEA (Nausea), PYREXIA (Fever) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided
Age: 70.0
Sex: U
Vaccine: COVID19
Symptoms: Tendonitis
Clinical narrative: right foot "tendonitis" prior to receiving vaccine but "feels like maybe it has it gotten a little worse"; This spontaneous case was reported by a consumer and describes the occurrence of TENDONITIS (right foot "tendonitis" prior to receiving vaccine but "feels like maybe it has it gotten a little worse") in a 70-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TENDONITIS (right foot "tendonitis" prior to receiving vaccine but "feels like maybe it has it gotten a little worse"). At the time of the report, TENDONITIS (right foot "tendonitis" prior to receiving vaccine but "feels like maybe it has it gotten a little worse") outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information not provided. Treatment included Voltaren cream
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Hyperhidrosis
Clinical narrative: Headache; sweating; joint pain; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (Headache), HYPERHIDROSIS (sweating) and ARTHRALGIA (joint pain) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.    On 09-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced HEADACHE (Headache), HYPERHIDROSIS (sweating) and ARTHRALGIA (joint pain). At the time of the report, HEADACHE (Headache), HYPERHIDROSIS (sweating) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information not provided. Treatment information not provided
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Sleep deficit
Clinical narrative: Very sever itching which last for 3 week; Patient could not even sleep due to itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Very sever itching which last for 3 week) and SLEEP DEFICIT (Patient could not even sleep due to itching) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event reported.).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced PRURITUS (Very sever itching which last for 3 week) and SLEEP DEFICIT (Patient could not even sleep due to itching). At the time of the report, PRURITUS (Very sever itching which last for 3 week) and SLEEP DEFICIT (Patient could not even sleep due to itching) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information not provided. Treatment information not provided
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Pruritus
Clinical narrative: Itching of the calves; Left arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching of the calves) and INJECTION SITE PAIN (Left arm was sore) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0011M20A) for COVID-19 vaccination.     The patient's past medical history included Hypertension since an unknown date and Cholesterol (High) since an unknown date.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PRURITUS (Itching of the calves) and INJECTION SITE PAIN (Left arm was sore). On 09-Feb-2021, INJECTION SITE PAIN (Left arm was sore) had resolved. At the time of the report, PRURITUS (Itching of the calves) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant included blood pressure medication and cholesterol medication Treatment included Chigger tropical cream
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: A body rash on my back, stomach, trunk, arms, and legs, rash itches; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (A body rash on my back, stomach, trunk, arms, and legs, rash itches) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 29-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced RASH PRURITIC (A body rash on my back, stomach, trunk, arms, and legs, rash itches). At the time of the report, RASH PRURITIC (A body rash on my back, stomach, trunk, arms, and legs, rash itches) outcome was unknown. Not Provided          Concomitant information not provided. Treatment information not provided
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Having temperature between 99 and less than 101,has been on and off for 8 days; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Having temperature between 99 and less than 101,has been on and off for 8 days) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PYREXIA (Having temperature between 99 and less than 101,has been on and off for 8 days). At the time of the report, PYREXIA (Having temperature between 99 and less than 101,has been on and off for 8 days) outcome was unknown. Not Provided          Concomitant information not provided. Treatment included Tylenol and Fever
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination site erythema, Vaccination site rash, Vaccination site warmth
Clinical narrative: Rash; Heat; Redness; nauseas; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash), VACCINATION SITE WARMTH (Heat), VACCINATION SITE ERYTHEMA (Redness) and NAUSEA (nauseas) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash), VACCINATION SITE WARMTH (Heat), VACCINATION SITE ERYTHEMA (Redness) and NAUSEA (nauseas). At the time of the report, VACCINATION SITE RASH (Rash), VACCINATION SITE WARMTH (Heat), VACCINATION SITE ERYTHEMA (Redness) and NAUSEA (nauseas) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information not provided. Treatment information not provided
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Insomnia, Pain in extremity, Pyrexia
Clinical narrative: Her arm hurt till crying it was "Killing her"; 104°F fever; diarrhea; vomiting; pounding headache; could'nt sleep; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Her arm hurt till crying it was "Killing her"), PYREXIA (104°F fever), DIARRHOEA (diarrhea), VOMITING (vomiting) and HEADACHE (pounding headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (November).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (Her arm hurt till crying it was "Killing her"), PYREXIA (104°F fever), DIARRHOEA (diarrhea), VOMITING (vomiting), HEADACHE (pounding headache) and INSOMNIA (could'nt sleep). At the time of the report, PAIN IN EXTREMITY (Her arm hurt till crying it was "Killing her") had not resolved and PYREXIA (104°F fever), DIARRHOEA (diarrhea), VOMITING (vomiting), HEADACHE (pounding headache) and INSOMNIA (could'nt sleep) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information not provided. Treatment information not provided
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Her arm hurt till crying it was "Killing her"; 104°F fever; diarrhea; vomiting; pounding headache; could'nt sleep; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Her arm hurt till crying it was "Killing her"), PYREXIA (104°F fever), DIARRHOEA (diarrhea), VOMITING (vomiting) and HEADACHE (pounding headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (November).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (Her arm hurt till crying it was "Killing her"), PYREXIA (104°F fever), DIARRHOEA (diarrhea), VOMITING (vomiting), HEADACHE (pounding headache) and INSOMNIA (could'nt sleep). At the time of the report, PAIN IN EXTREMITY (Her arm hurt till crying it was "Killing her") had not resolved and PYREXIA (104°F fever), DIARRHOEA (diarrhea), VOMITING (vomiting), HEADACHE (pounding headache) and INSOMNIA (could'nt sleep) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information not provided. Treatment information not provided
Sex: F
Vaccine: COVID19
Symptoms: Blister
Clinical narrative: herpes blisters; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (herpes blisters) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included Blister.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced BLISTER (herpes blisters). On 10-Feb-2021, BLISTER (herpes blisters) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information not provided. Treatment information not provided   This case was linked to MOD-2021-031239 (E2B Linked Report).; Sender's Comments:  MOD-2021-031239:Sister case
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Lip swelling, Vaccination site pruritus
Clinical narrative: Swollen Lip; Itchiness ( Injection Site); This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Swollen Lip) and VACCINATION SITE PRURITUS (Itchiness ( Injection Site)) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced LIP SWELLING (Swollen Lip) and VACCINATION SITE PRURITUS (Itchiness ( Injection Site)). At the time of the report, LIP SWELLING (Swollen Lip) and VACCINATION SITE PRURITUS (Itchiness ( Injection Site)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information not provided. Treatment information not provided
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Vaccination site erythema, Vaccination site swelling
Clinical narrative: injection site was swollen; arm was sore; red dot appeared at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (arm was sore), VACCINATION SITE ERYTHEMA (red dot appeared at the injection site) and VACCINATION SITE SWELLING (injection site was swollen) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.  On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 10-Feb-2021, the patient experienced AXILLARY PAIN (arm was sore) and VACCINATION SITE ERYTHEMA (red dot appeared at the injection site).   On 11-Feb-2021, the patient experienced VACCINATION SITE SWELLING (injection site was swollen).   At the time of the report, AXILLARY PAIN (arm was sore), VACCINATION SITE ERYTHEMA (red dot appeared at the injection site) and VACCINATION SITE SWELLING (injection site was swollen) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: chills; a 102°F fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (a 102°F fever) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Fibromyalgia and Cholesterol blood excessive.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced CHILLS (chills), PYREXIA (a 102°F fever) and HEADACHE (headache). The patient was treated with ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 16-Jan-2021, CHILLS (chills), PYREXIA (a 102°F fever) and HEADACHE (headache) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 102 f 102 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medications included medicines for high blood pressure, fibromyalgia, cholesterol.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Inappropriate schedule of product administration, Vaccination site rash
Clinical narrative: redness on arms and legs; received second dose after 5 weeks; red blotch at her injection site; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness on arms and legs), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received second dose after 5 weeks) and VACCINATION SITE RASH (red blotch at her injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE RASH (red blotch at her injection site). On an unknown date, the patient experienced ERYTHEMA (redness on arms and legs) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received second dose after 5 weeks). At the time of the report, ERYTHEMA (redness on arms and legs), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received second dose after 5 weeks) and VACCINATION SITE RASH (red blotch at her injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       treatment medication cortizone cream were reported   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: added event, dosage form
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased
Clinical narrative: Pulse is around 117 beats per minute; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEART RATE INCREASED (Pulse is around 117 beats per minute) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.). Concomitant products included AMLODIPINE, HCTZ and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 09-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 09-Feb-2021, the patient experienced HEART RATE INCREASED (Pulse is around 117 beats per minute). At the time of the report, HEART RATE INCREASED (Pulse is around 117 beats per minute) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 117 117.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Back pain, Decreased appetite, Flank pain, Illness
Clinical narrative: no appetite; No energy; Back ache; Pain on left flank; Sick; nausea; Vomiting; Extreme flu symptoms; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), NAUSEA (nausea), VOMITING (Vomiting), INFLUENZA (Extreme flu symptoms) and DECREASED APPETITE (no appetite) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.).   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced ILLNESS (Sick), NAUSEA (nausea), VOMITING (Vomiting) and INFLUENZA (Extreme flu symptoms). On 11-Feb-2021, the patient experienced DECREASED APPETITE (no appetite), ASTHENIA (No energy), BACK PAIN (Back ache) and FLANK PAIN (Pain on left flank). At the time of the report, ILLNESS (Sick), VOMITING (Vomiting) and INFLUENZA (Extreme flu symptoms) outcome was unknown and NAUSEA (nausea), DECREASED APPETITE (no appetite), ASTHENIA (No energy), BACK PAIN (Back ache) and FLANK PAIN (Pain on left flank) had not resolved.            Concomitant medication includes high blood pressure medication. Treatment information was not provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza, Nausea, Vomiting
Clinical narrative: no appetite; No energy; Back ache; Pain on left flank; Sick; nausea; Vomiting; Extreme flu symptoms; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), NAUSEA (nausea), VOMITING (Vomiting), INFLUENZA (Extreme flu symptoms) and DECREASED APPETITE (no appetite) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.).   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced ILLNESS (Sick), NAUSEA (nausea), VOMITING (Vomiting) and INFLUENZA (Extreme flu symptoms). On 11-Feb-2021, the patient experienced DECREASED APPETITE (no appetite), ASTHENIA (No energy), BACK PAIN (Back ache) and FLANK PAIN (Pain on left flank). At the time of the report, ILLNESS (Sick), VOMITING (Vomiting) and INFLUENZA (Extreme flu symptoms) outcome was unknown and NAUSEA (nausea), DECREASED APPETITE (no appetite), ASTHENIA (No energy), BACK PAIN (Back ache) and FLANK PAIN (Pain on left flank) had not resolved.            Concomitant medication includes high blood pressure medication. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pain in extremity, Vision blurred
Clinical narrative: arm is sore; Dizzy; Couldn't see real good; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm is sore), DIZZINESS (Dizzy) and VISION BLURRED (Couldn't see real good) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm is sore), DIZZINESS (Dizzy) and VISION BLURRED (Couldn't see real good). At the time of the report, PAIN IN EXTREMITY (arm is sore), DIZZINESS (Dizzy) and VISION BLURRED (Couldn't see real good) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided. Concomitant medication was not provided.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive covid test) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. No Medical History information was reported. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced COVID-19 (Positive covid test). At the time of the report, COVID-19 (Positive covid test) had resolved. Not Provided. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Jan-2021, SARS-CoV-2 test: (Positive) Positive. On an unknown date, SARS-CoV-2 test: (Negative) Negative. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications provided. No treatment medications provided.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Injection site itchiness) and VACCINATION SITE ERYTHEMA (Big Red Mark (injection Site)) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 16-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site itchiness) and VACCINATION SITE ERYTHEMA (Big Red Mark (injection Site)). At the time of the report, VACCINATION SITE PRURITUS (Injection site itchiness) and VACCINATION SITE ERYTHEMA (Big Red Mark (injection Site)) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not provided.  Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dizziness, Erythema, Feeling abnormal
Clinical narrative: Dizziness; Felt bad; Increased heartrate; Felt weak; Face turned blood red; Chills,could not get warm; Felt nauseated; Left arm was swollen with a 3 inch diameter spot on arm; Felt achy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), FEELING ABNORMAL (Felt bad), HEART RATE INCREASED (Increased heartrate), ASTHENIA (Felt weak) and ERYTHEMA (Face turned blood red) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (patient had coronavirus in September 2020.) in September 2020.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 07-Feb-2021, the patient experienced DIZZINESS (Dizziness), FEELING ABNORMAL (Felt bad), HEART RATE INCREASED (Increased heartrate), ASTHENIA (Felt weak), ERYTHEMA (Face turned blood red), CHILLS (Chills,could not get warm), NAUSEA (Felt nauseated), VACCINATION SITE SWELLING (Left arm was swollen with a 3 inch diameter spot on arm) and MYALGIA (Felt achy). At the time of the report, DIZZINESS (Dizziness), FEELING ABNORMAL (Felt bad), HEART RATE INCREASED (Increased heartrate), ASTHENIA (Felt weak), ERYTHEMA (Face turned blood red), CHILLS (Chills,could not get warm), NAUSEA (Felt nauseated), VACCINATION SITE SWELLING (Left arm was swollen with a 3 inch diameter spot on arm) and MYALGIA (Felt achy) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2020, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Heart rate increased, Myalgia, Nausea, SARS-CoV-2 test, Vaccination site swelling
Clinical narrative: Dizziness; Felt bad; Increased heartrate; Felt weak; Face turned blood red; Chills,could not get warm; Felt nauseated; Left arm was swollen with a 3 inch diameter spot on arm; Felt achy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), FEELING ABNORMAL (Felt bad), HEART RATE INCREASED (Increased heartrate), ASTHENIA (Felt weak) and ERYTHEMA (Face turned blood red) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (patient had coronavirus in September 2020.) in September 2020.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 07-Feb-2021, the patient experienced DIZZINESS (Dizziness), FEELING ABNORMAL (Felt bad), HEART RATE INCREASED (Increased heartrate), ASTHENIA (Felt weak), ERYTHEMA (Face turned blood red), CHILLS (Chills,could not get warm), NAUSEA (Felt nauseated), VACCINATION SITE SWELLING (Left arm was swollen with a 3 inch diameter spot on arm) and MYALGIA (Felt achy). At the time of the report, DIZZINESS (Dizziness), FEELING ABNORMAL (Felt bad), HEART RATE INCREASED (Increased heartrate), ASTHENIA (Felt weak), ERYTHEMA (Face turned blood red), CHILLS (Chills,could not get warm), NAUSEA (Felt nauseated), VACCINATION SITE SWELLING (Left arm was swollen with a 3 inch diameter spot on arm) and MYALGIA (Felt achy) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2020, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Heat of the site; Redness of the site; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Heat of the site) and VACCINATION SITE ERYTHEMA (Redness of the site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Heat of the site) and VACCINATION SITE ERYTHEMA (Redness of the site). At the time of the report, VACCINATION SITE WARMTH (Heat of the site) and VACCINATION SITE ERYTHEMA (Redness of the site) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort
Clinical narrative: Couldn't Move Arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Couldn't Move Arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (Couldn't Move Arm). At the time of the report, LIMB DISCOMFORT (Couldn't Move Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided. Treatment information was not provided.   This case was linked (E2B Linked Report).; Sender's Comments:  Patient case
Sex: F
Vaccine: COVID19
Symptoms: Illness, Neuralgia, Pain, Rash
Clinical narrative: Nerve pain; very ill; intense pain in their back, their hip and down their leg; rash on their chest and stomach, that did not last long, and was not itchy nor burning; This spontaneous case was reported by a consumer and describes the occurrence of NEURALGIA (Nerve pain), ILLNESS (very ill), PAIN (intense pain in their back, their hip and down their leg) and RASH (rash on their chest and stomach, that did not last long, and was not itchy nor burning) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NEURALGIA (Nerve pain), ILLNESS (very ill), PAIN (intense pain in their back, their hip and down their leg) and RASH (rash on their chest and stomach, that did not last long, and was not itchy nor burning). At the time of the report, NEURALGIA (Nerve pain), ILLNESS (very ill), PAIN (intense pain in their back, their hip and down their leg) and RASH (rash on their chest and stomach, that did not last long, and was not itchy nor burning) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.  Concomitant medication was not provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site movement impairment, Vaccination site swelling
Clinical narrative: She cannot move/use her arm at all; Her arm swelled up  her entire arm, down to her hand; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (She cannot move/use her arm at all) and VACCINATION SITE SWELLING (Her arm swelled up  her entire arm, down to her hand) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (She cannot move/use her arm at all) and VACCINATION SITE SWELLING (Her arm swelled up  her entire arm, down to her hand). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (She cannot move/use her arm at all) and VACCINATION SITE SWELLING (Her arm swelled up  her entire arm, down to her hand) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant and treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Follow up was received on 23-APR-2021. All events' outcome was updated to recovered/resolved.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pruritus, Pyrexia
Clinical narrative: Itchy little bumps on both legs and arms; Low grade fever; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever), PAIN (Body aches) and PRURITUS (Itchy little bumps on both legs and arms) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced PYREXIA (Low grade fever) and PAIN (Body aches). On 05-Feb-2021, the patient experienced PRURITUS (Itchy little bumps on both legs and arms). At the time of the report, PYREXIA (Low grade fever), PAIN (Body aches) and PRURITUS (Itchy little bumps on both legs and arms) outcome was unknown. Not Provided          Treatment includes topical itchy medication. Concomitant medication was not provided.   Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: TCR received on 22-Apr-2021. Event outcome was updated.
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Pyrexia
Clinical narrative: Has a fever; Started losing her voice; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Has a fever) and APHONIA (Started losing her voice) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Not provided) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Hypertension, High cholesterol and Diabetes. Concomitant products included OMEPRAZOLE.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PYREXIA (Has a fever) and APHONIA (Started losing her voice). At the time of the report, PYREXIA (Has a fever) and APHONIA (Started losing her voice) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Rash, Vaccination site rash
Clinical narrative: Redness; Big round rash; Rash at the site; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (Redness), RASH (Big round rash) and VACCINATION SITE RASH (Rash at the site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced ERYTHEMA (Redness), RASH (Big round rash) and VACCINATION SITE RASH (Rash at the site). At the time of the report, ERYTHEMA (Redness), RASH (Big round rash) and VACCINATION SITE RASH (Rash at the site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood pressure increased, Decreased appetite, Dizziness, Feeling abnormal
Clinical narrative: Dizzy; Fogginess; Blood pressure spikes; Anxious; Did not have much of an appetite; Real stick to her stomach and threw up; Nauseous; Pain in left kidney area; Bleeding after shot; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), FEELING ABNORMAL (Fogginess), BLOOD PRESSURE INCREASED (Blood pressure spikes), VACCINATION SITE HAEMORRHAGE (Bleeding after shot) and ANXIETY (Anxious) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included AMLODIPINE, CLONIDINE, ONDANSETRON and TOCOPHERYL ACETATE (VITAMINE E) for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (Bleeding after shot). On 10-Feb-2021, the patient experienced RENAL PAIN (Pain in left kidney area). On an unknown date, the patient experienced DIZZINESS (Dizzy), FEELING ABNORMAL (Fogginess), BLOOD PRESSURE INCREASED (Blood pressure spikes), ANXIETY (Anxious), DECREASED APPETITE (Did not have much of an appetite), VOMITING (Real stick to her stomach and threw up) and NAUSEA (Nauseous). The patient was treated with ONDANSETRON at an unspecified dose and frequency. On 03-Feb-2021, VACCINATION SITE HAEMORRHAGE (Bleeding after shot) outcome was unknown. At the time of the report, DIZZINESS (Dizzy), FEELING ABNORMAL (Fogginess), BLOOD PRESSURE INCREASED (Blood pressure spikes), ANXIETY (Anxious), DECREASED APPETITE (Did not have much of an appetite), RENAL PAIN (Pain in left kidney area), VOMITING (Real stick to her stomach and threw up) and NAUSEA (Nauseous) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Renal pain, Vaccination site haemorrhage, Vomiting
Clinical narrative: Dizzy; Fogginess; Blood pressure spikes; Anxious; Did not have much of an appetite; Real stick to her stomach and threw up; Nauseous; Pain in left kidney area; Bleeding after shot; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), FEELING ABNORMAL (Fogginess), BLOOD PRESSURE INCREASED (Blood pressure spikes), VACCINATION SITE HAEMORRHAGE (Bleeding after shot) and ANXIETY (Anxious) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included AMLODIPINE, CLONIDINE, ONDANSETRON and TOCOPHERYL ACETATE (VITAMINE E) for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (Bleeding after shot). On 10-Feb-2021, the patient experienced RENAL PAIN (Pain in left kidney area). On an unknown date, the patient experienced DIZZINESS (Dizzy), FEELING ABNORMAL (Fogginess), BLOOD PRESSURE INCREASED (Blood pressure spikes), ANXIETY (Anxious), DECREASED APPETITE (Did not have much of an appetite), VOMITING (Real stick to her stomach and threw up) and NAUSEA (Nauseous). The patient was treated with ONDANSETRON at an unspecified dose and frequency. On 03-Feb-2021, VACCINATION SITE HAEMORRHAGE (Bleeding after shot) outcome was unknown. At the time of the report, DIZZINESS (Dizzy), FEELING ABNORMAL (Fogginess), BLOOD PRESSURE INCREASED (Blood pressure spikes), ANXIETY (Anxious), DECREASED APPETITE (Did not have much of an appetite), RENAL PAIN (Pain in left kidney area), VOMITING (Real stick to her stomach and threw up) and NAUSEA (Nauseous) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site swelling
Clinical narrative: Swelling arm; Hardness; Redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling arm), VACCINATION SITE INDURATION (Hardness) and VACCINATION SITE ERYTHEMA (Redness) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Swelling arm), VACCINATION SITE INDURATION (Hardness) and VACCINATION SITE ERYTHEMA (Redness). At the time of the report, VACCINATION SITE SWELLING (Swelling arm), VACCINATION SITE INDURATION (Hardness) and VACCINATION SITE ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.